Compare CGEM & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGEM | TIPT |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 780.4M | 653.2M |
| IPO Year | N/A | N/A |
| Metric | CGEM | TIPT |
|---|---|---|
| Price | $12.10 | $17.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $28.80 | N/A |
| AVG Volume (30 Days) | ★ 676.1K | 197.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.68 | $17.07 |
| 52 Week High | $13.43 | $27.41 |
| Indicator | CGEM | TIPT |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 55.14 |
| Support Level | $11.40 | $17.26 |
| Resistance Level | $12.55 | $17.81 |
| Average True Range (ATR) | 0.87 | 0.40 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 32.85 | 68.11 |
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.